CHEK2 / CHK2

CHK2 antibody LS-C114493 is an unconjugated mouse monoclonal antibody to CHK2 (CHEK2) from human. It is reactive with human and dog. Validated for Flow, IHC, IP and WB.

Antibodies Primary

Article No

LS-C114493-100

Size

100 µl

Clone

OTI4C10

Source / Host

mouse

Shipping Information

RT

Application

FC, IHC, IP, WB

Species Reactivity

dog/canine
human

Article No

LS-C114493-100

Size

100 µl

Clone

OTI4C10

Source / Host

mouse

Shipping Information

RT

Application

FC, IHC, IP, WB

Species Reactivity

dog/canine
human

Specifications

NCBI Number 11200
Application FC, IHC, IP, WB
Article No LS-C114493-100
Country Availability SE, FI, DK, NO, FO, GL
Clone OTI4C10
Clone Type monoclonal
Concentration 1.88 mg/ml
Conjugation Unconjugated
Description CHK2 antibody LS-C114493 is an unconjugated mouse monoclonal antibody to CHK2 (CHEK2) from human. It is reactive with human and dog. Validated for Flow, IHC, IP and WB.
Recommended Dilution FC (1:100), IHC-P (1:150), WB (1:1000 - 1:2000)
Supplier LifeSpan Biosciences
Entrez Gene ID 11200
Gene Symbol CHEK2
Immunogen Full length human recombinant protein of human CHEK2 (NP_009125) produced in HEK293T cell.
Isotype IgG2b
Notes CHK2 antibody LS-C114493 is an unconjugated mouse monoclonal antibody to CHK2 (CHEK2) from human. It is reactive with human and dog. Validated for Flow, IHC, IP and WB.
Alias Names CHEK2, BA444G7, Cds1 homolog, Checkpoint kinase 2, Checkpoint-like protein CHK2, CHK2 checkpoint homolog, CHK2, HCds1, LFS2, RAD53, Rad53 homolog, HCHK2, HuCds1, PP1425
Product Type Antibodies Primary
Protocol Concentration: 0.5-1.0 mg/ml (Lot dependent)
Purification Protein A/G Purified
Shipping Information RT
Size 100 µl
Source / Host mouse
Species Reactivity dog/canine, human
Storage -20°C
Substrate / Buffer PBS, pH 7.3, 0.02% Sodium Azide, 50% Glycerol, 1% BSA
Technical Specifications Human Chk2
Product Page Updated 2024-04-12T06:35:05.844Z
Volume 100 µl

Documentation

Shipping info
The delivery time for this item is approximately 9-18 business days. Read more